I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: AVACTA ORD 10P AVCT Announcements

AVACTA ORD 10P (AVCT) Announcements

Date Time Source Announcement
11 Aug 2020 9:30 am
RNS
Holding(s) in Company
  7:00 am
RNS
Therapeutics Chief Development Officer Appointment
07 Aug 2020 7:00 am
RNS
SARS-CoV-2 Antigen Test Clinical Collaboration
06 Aug 2020 7:00 am
RNS
COVID-19 Rapid Antigen Test Manufacturing Partner
29 Jul 2020 7:00 am
RNS
Expanded Partnership with Daewoong Pharmaceutical
22 Jul 2020 7:00 am
RNS
Update on Adeptrix COVID-19 Diagnostic Test
17 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
13 Jul 2020 7:00 am
RNS
Collaboration with Integumen plc
07 Jul 2020 2:06 pm
RNS
Issue of Equity
03 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
24 Jun 2020 11:15 am
RNS
Result of General Meeting
  7:00 am
RNS
Update on COVID-19 Test Development Partnership
22 Jun 2020 2:52 pm
RNS
Result of AGM
18 Jun 2020 7:00 am
RNS
Update on Affimer? Therapy for COVID-19 Infection
17 Jun 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
15 Jun 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
12 Jun 2020 7:00 am
RNS
Holding(s) in Company
10 Jun 2020 6:35 pm
RNS
Holding(s) in Company
09 Jun 2020 7:01 am
RNS
Investor Presentation
  7:00 am
RNS
Update on COVID-19 Test Development with Adeptrix
08 Jun 2020 4:15 pm
RNS
Posting of Circular and Notice of General Meeting
04 Jun 2020 5:16 pm
RNS
Director/PDMR Shareholding
  5:15 pm
RNS
Result of Fundraising
  12:30 pm
RNS
Increase in Fundraising
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:01 am
RNS
PrimaryBid.com Offers
  7:00 am
RNS
Proposed Fundraising to raise up to �45 million
28 May 2020 7:00 am
RNS
Posting of Annual Report and Notice of AGM
26 May 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  8:06 am
RNS
Issue of Equity
21 May 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
20 May 2020 7:00 am
RNS
Distribution Agreement for COVID-19 Antigen Test
15 May 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:30 am
RNS
Issue of Equity
  7:00 am
RNS
SARS-COV-2 Neutralising Affimers
11 May 2020 7:00 am
RNS
Avacta Ships SARS-COV-2 Affimer Reagents
06 May 2020 7:00 am
RNS
Results for the period ending 31 December 2019
05 May 2020 6:15 pm
RNS
Holding(s) in Company
04 May 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
01 May 2020 7:00 am
RNS
COVID-19 Antigen Test Collaboration with Adeptrix
27 Apr 2020 5:30 pm
RNS
Holding(s) in Company
  5:00 pm
RNS
Holding(s) in Company
24 Apr 2020 6:00 pm
RNS
Holding(s) in Company
  4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
23 Apr 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  10:18 am
RNS
Result of General Meeting
22 Apr 2020 2:30 pm
RNS
Holding(s) in Company
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Avacta/Cytiva Partnership Ahead of Schedule
20 Apr 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
17 Apr 2020 7:00 am
RNS
Notice of Results - Update
16 Apr 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
15 Apr 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
14 Apr 2020 5:30 pm
RNS
Holding(s) in Company
  2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
09 Apr 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
08 Apr 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Avacta & Cytiva Collaborate on COVID-19 Rapid Test
06 Apr 2020 5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
  2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Proposed Placing to raise �3.75 million
02 Apr 2020 7:01 am
RNS
Appointment of Joint Broker
  7:00 am
RNS
Subscription to raise �2 million
26 Mar 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
24 Mar 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
16 Mar 2020 4:42 pm
RNS
Second Price Monitoring Extn
  4:38 pm
RNS
Price Monitoring Extension
10 Mar 2020 7:00 am
RNS
Shareholder/Investor Meeting and Presentation
13 Feb 2020 7:00 am
RNS
Notice of Results
11 Feb 2020 7:00 am
RNS
Share Incentive Plan/Issue of Equity
03 Feb 2020 7:00 am
RNS
Avacta and Daewoong Agreement
29 Jan 2020 2:45 pm
RNS
Holding(s) in Company
28 Jan 2020 7:00 am
RNS
Successful initial proof-of-concept
23 Jan 2020 7:00 am
RNS
Trading Update
21 Jan 2020 7:00 am
RNS
Director Appointment
08 Jan 2020 7:00 am
RNS
Avacta and Daewoong Establish Joint Venture
26 Nov 2019 9:00 am
RNS
Holding(s) in Company
  9:00 am
RNS
Holding(s) in Company
22 Nov 2019 8:41 am
RNS
Director/PDMR Shareholding
13 Nov 2019 7:00 am
RNS
LG Chem Life Sciences Expands Partnership
11 Nov 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
08 Nov 2019 6:30 pm
RNS
Holding(s) in Company
  6:26 pm
RNS
Holding(s) in Company
07 Nov 2019 1:00 pm
RNS
Holding(s) in Company
  11:00 am
RNS
Holding(s) in Company
06 Nov 2019 2:30 pm
RNS
Holding(s) in Company
  2:30 pm
RNS
Holding(s) in Company
04 Nov 2019 1:18 pm
RNS
Result of General Meeting
18 Oct 2019 12:06 pm
RNS
Proposed Placing & Subscription to raise up to �9M
  12:05 pm
RNS
Interim Results for the Period Ended 31 July 2019
10 Oct 2019 7:00 am
RNS
Collaboration with ADC Therapeutics
05 Aug 2019 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
29 Jul 2019 7:00 am
RNS
Avacta's CEO to Present at Biotech Investor Day
20 Jun 2019 7:00 am
RNS
Avacta and Selexis Partner to Develop Cell Line
19 Jun 2019 7:00 am
RNS
Turner Pope Investor Evening
12 Jun 2019 7:00 am
RNS
Avacta's CSO to Present at Major US Conference
10 Jun 2019 7:00 am
RNS
Avacta hits Clinical Candidate Selection Milestone
03 Jun 2019 7:00 am
RNS
TMAC Programme Accelerates
23 Apr 2019 3:48 pm
RNS
Issue of Equity
12 Apr 2019 2:46 pm
RNS
Holding(s) in Company
09 Apr 2019 7:00 am
RNS
Interim Results
08 Mar 2019 12:14 pm
RNS
Issue of Equity
06 Feb 2019 12:27 pm
EQS
Avacta (AVCT): A second wake-up call for the ma...
04 Feb 2019 7:00 am
RNS
Moderna Exercises Exclusive Product License Option
28 Jan 2019 7:00 am
RNS
Director Appointment
21 Jan 2019 3:40 pm
RNS
Result of Annual General Meeting
  7:00 am
RNS
AGM Business Update and Notice of Results
18 Jan 2019 5:08 pm
RNS
Share Incentive Plan/Issue of Equity
  10:00 am
RNS
Change of accounting reference date
09 Jan 2019 11:06 am
RNS
Holding(s) in Company
  11:06 am
RNS
Holding(s) in Company
07 Jan 2019 2:50 pm
RNS
Director/PDMR Shareholdings
03 Jan 2019 8:56 am
RNS
Holding(s) in Company
  8:56 am
RNS
Holding(s) in Company
02 Jan 2019 7:00 am
RNS
Director/PDMR Shareholding
21 Dec 2018 1:41 pm
RNS
Holding(s) in Company
19 Dec 2018 3:32 pm
RNS
Holding(s) in Company
17 Dec 2018 7:00 am
RNS
Avacta London Science Day
12 Dec 2018 12:50 pm
RNS
Holding(s) in Company
  12:44 pm
RNS
Holding(s) in Company
  12:44 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Appointment of Chief Medical Officer
11 Dec 2018 7:00 am
RNS
Posting of Annual Report and Notice of AGM
10 Dec 2018 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:30 am
EQS
Avacta (AVCT): Wake-up call for the market
  7:00 am
RNS
Development Partnership with LG Chem Life Sciences
12 Nov 2018 7:00 am
RNS
Avacta to Present at Major European Conference
11 Oct 2018 7:00 am
RNS
Avacta's CTO to Present at Major US Conference
10 Oct 2018 7:00 am
RNS
Avacta agrees Affimer reagent licensing deal
02 Oct 2018 7:00 am
RNS
Preliminary Results
21 Sep 2018 7:00 am
RNS
Investor Meeting and Presentation
05 Sep 2018 7:15 am
EQS
Avacta (AVCT): Capital increase for further dev...
  7:00 am
RNS
Notice of Results
31 Aug 2018 9:55 am
RNS
Holding(s) in Company
  9:55 am
RNS
Holding(s) in Company
23 Aug 2018 5:07 pm
RNS
Holding(s) in Company
  5:06 pm
RNS
Holding(s) in Company
  11:21 am
RNS
Holding(s) in Company
22 Aug 2018 2:23 pm
RNS
Holding(s) in Company
  9:20 am
RNS
Holding(s) in Company
17 Aug 2018 11:30 am
RNS
Result of General Meeting
06 Aug 2018 4:24 pm
RNS
Holding(s) in Company
  4:24 pm
RNS
Holding(s) in Company
30 Jul 2018 6:06 pm
RNS
Results of Placing and Subscription
  11:41 am
RNS
Proposed Placing and Subscription to raise �11.4m
  10:35 am
EQS
Avacta (AVCT): Ground-breaking new drug conjuga...
24 Jul 2018 7:00 am
RNS
Major Therapeutics Co-development Partnership
26 Jun 2018 1:30 pm
EQS
Avacta (AVCT): Gearing up the management team
11 Jun 2018 7:00 am
RNS
Appointment of Non-Executive Chairman
31 May 2018 12:15 pm
EQS
Avacta (AVCT): In vivo expression of Affimers
22 May 2018 7:00 am
RNS
Successful Outcome of Study with FIT Biotech
30 Apr 2018 4:45 pm
RNS
Holding(s) in Company
17 Apr 2018 7:15 am
EQS
Avacta (AVCT): Commendable rate of progress
16 Apr 2018 7:25 am
RNS
Interim Results
09 Apr 2018 2:58 pm
RNS
Issue of Equity
29 Mar 2018 7:00 am
RNS
Avacta to Present at Investor Forum
  7:00 am
RNS
Directorate Change
13 Mar 2018 12:02 pm
RNS
Director/PDMR Shareholding
07 Mar 2018 4:35 pm
RNS
Price Monitoring Extension
08 Feb 2018 7:00 am
RNS
Summary of Capital Markets Day
22 Jan 2018 7:00 am
RNS
Avacta and OncoSec to Collaborate
18 Jan 2018 11:26 am
RNS
Result of Annual General Meeting
  7:00 am
RNS
AGM Business Update and Notice of Results
15 Jan 2018 10:58 am
RNS
HardmanResearch: Affimer Drug Conjugates a reality
  7:00 am
RNS
Drug Development Partnership with Glythera
08 Jan 2018 7:00 am
RNS
Capital Markets Day Notification
04 Jan 2018 11:04 am
RNS
PDMR Dealing and Issue of Equity
03 Jan 2018 7:00 am
RNS
Presenting at the Biotech Showcase, San Francisco
18 Dec 2017 4:28 pm
RNS
Issue of Equity
04 Dec 2017 11:03 am
RNS
Posting of Annual Report and Notice of AGM
30 Nov 2017 10:57 am
RNS
Issue of Equity
15 Nov 2017 7:00 am
RNS
Covance to Present Affimer Data at Conference
14 Nov 2017 3:27 pm
RNS
Holding(s) in Company
13 Nov 2017 7:00 am
RNS
Avacta to Present at Investor Evening
  7:00 am
RNS
Avacta to present at PEGS Europe
24 Oct 2017 7:00 am
RNS
Affimers in Scientific Publications
19 Oct 2017 7:00 am
RNS
Private Shareholder Update Event
16 Oct 2017 10:42 am
RNS
Hardman Res.: R&D accelerated to advance assets
12 Oct 2017 7:00 am
RNS
Avacta to Present at Shares Spotlight Evening
10 Oct 2017 7:00 am
RNS
Avacta to Present at Major US Conference
09 Oct 2017 4:02 pm
RNS
Director Dealing and Issue of Equity
05 Oct 2017 7:00 am
RNS
Research collaboration with FIT Biotech Oy
04 Oct 2017 7:00 am
RNS
Preliminary Results
02 Oct 2017 7:00 am
RNS
Avacta establishes US business development team
07 Sep 2017 7:00 am
RNS
Notice of Results
21 Aug 2017 12:00 pm
RNS
Director/PDMR Shareholding
07 Aug 2017 7:00 am
RNS
Trading Update
31 Jul 2017 12:00 pm
RNS
Issue of Equity
28 Jul 2017 1:15 pm
RNS
Director/PDMR Shareholding
05 Jul 2017 7:00 am
RNS
Director Dealing and Issue of Equity
04 Jul 2017 7:00 am
RNS
Manchester ShareSoc Growth Company Seminar
05 Jun 2017 7:00 am
RNS
ShareSoc Growth Company Seminar
01 Jun 2017 8:56 am
RNS
Issue of Equity
22 May 2017 7:00 am
RNS
2 Biotech's Licence Affimers for Research Use
10 May 2017 7:00 am
RNS
Key Affimer Patent To Be Granted in China
08 May 2017 1:21 pm
RNS
Hardman Research: De-risking Moderna's partnership
05 May 2017 7:00 am
RNS
Presenting at the Hardman Private Investor Forum
02 May 2017 7:00 am
RNS
Avacta to Present at BioTrinity 2017
24 Apr 2017 7:00 am
RNS
Diagnostics firm take rights to several Affimers
19 Apr 2017 7:00 am
RNS
Avacta to Present at the Shares Spotlight Evening
12 Apr 2017 7:15 am
RNS
Hardman Research: Another important box ticked
06 Apr 2017 2:23 pm
RNS
Holding(s) in Company
  2:23 pm
RNS
Holding(s) in Company
  10:22 am
RNS
Director/PDMR Shareholding
03 Apr 2017 7:00 am
RNS
Interim Results for the Period Ended 31 Jan 2017
  7:00 am
RNS
Results of Immunogenicity Study with Human Samples
31 Mar 2017 9:31 am
RNS
Avacta Presents at Investor Evening Hosted by TPI
  7:00 am
RNS
London Growth and Innovation Forum Presentation
22 Mar 2017 9:00 am
RNS
Avacta to present at the UK Investor Show
21 Mar 2017 7:15 am
RNS
Hardman Research: Low response would be positive!
30 Jan 2017 7:00 am
RNS
Director/PDMR Shareholding
20 Jan 2017 11:35 am
RNS
Result of Annual General Meeting
  7:00 am
RNS
Trading Update
11 Jan 2017 7:00 am
RNS
Presenting at London Growth and Innovation Forum
05 Jan 2017 7:00 am
RNS
Director Dealing and Issue of Equity
20 Dec 2016 7:00 am
RNS
Director/PDMR Shareholding
16 Dec 2016 5:14 pm
RNS
Holding(s) in Company
01 Dec 2016 7:00 am
RNS
Notice of AGM, Accounts and Directorate Change
23 Nov 2016 7:00 am
RNS
Technical Update: Affinity Separation
07 Nov 2016 7:00 am
RNS
Cancer Expert joins Scientific Advisory Board
02 Nov 2016 7:00 am
RNS
CAR-T Cell Therapy Research Collaboration in US
01 Nov 2016 7:00 am
RNS
Results from first Affimer pre-clinical studies
21 Oct 2016 11:39 am
RNS
Director's Dealing
17 Oct 2016 1:00 pm
RNS
Hardman Research: Great strides to strategic goals
  7:00 am
RNS
Prelim Results for the Year Ended 31 July 2016
04 Oct 2016 3:28 pm
RNS
Issue of Equity
26 Sep 2016 11:21 am
RNS
Notice of Results
22 Sep 2016 7:00 am
RNS
Positive results from first preclinical studies
12 Sep 2016 7:00 am
RNS
Change of Adviser
31 Aug 2016 2:17 pm
RNS
Change of Registered Office
16 Aug 2016 7:00 am
RNS
New Facilities in Cambridge and Wetherby
10 Aug 2016 7:00 am
RNS
Grant Funding
03 Aug 2016 7:00 am
RNS
Key Affimer patents to be granted in Europe and US
01 Aug 2016 7:00 am
RNS
Trading Statement
19 Jul 2016 3:13 pm
RNS
Holding(s) in Company
  7:15 am
RNS
Hardman report: New Affimer opportunities
14 Jul 2016 7:00 am
RNS
Collaboration with Glythera
08 Jul 2016 7:00 am
RNS
Director/PDMR Shareholding
22 Jun 2016 7:00 am
RNS
Affimer Binders for Zika Virus Diagnostics
16 Jun 2016 11:08 am
RNS
Issue of Equity
13 Jun 2016 7:00 am
RNS
Collaboration with Mologic
29 Apr 2016 3:04 pm
RNS
Director's Dealing
25 Apr 2016 7:00 am
RNS
Half-year Report
19 Apr 2016 7:00 am
RNS
Affimer Therapeutic Platform Development Milestone
07 Apr 2016 7:00 am
RNS
Director's Dealing
05 Apr 2016 7:00 am
RNS
Investor Evening
15 Mar 2016 7:00 am
RNS
Issue of Equity
07 Mar 2016 7:00 am
RNS
Avacta Establishes Scientific Advisory Board
25 Feb 2016 4:34 pm
RNS
Holding(s) in Company
  4:34 pm
RNS
Holding(s) in Company
24 Feb 2016 7:00 am
RNS
Grant Funding Awarded
23 Feb 2016 10:54 am
RNS
Hardman & Co Issues Research Report
  7:00 am
RNS
Director's Dealing
17 Feb 2016 7:00 am
RNS
Directors' Dealings and Issue of Equity
26 Jan 2016 8:05 am
RNS
Share Consolidation
25 Jan 2016 3:35 pm
RNS
Result of Annual General Meeting
  7:01 am
RNS
Pre-close trading update
  7:00 am
RNS
Philippe Cotrel Appointed Chief Commercial Officer
21 Jan 2016 7:00 am
RNS
Proposed Shareholder Consolidation
07 Jan 2016 7:00 am
RNS
Posting of Annual Report & Accounts and AGM Notice
05 Jan 2016 7:00 am
RNS
Issue of Equity
10 Dec 2015 7:00 am
RNS
Appointment of Tony Gardiner as CFO
01 Dec 2015 4:44 pm
RNS
Holding(s) in Company
30 Nov 2015 7:00 am
RNS
Issue of Equity
23 Nov 2015 7:00 am
RNS
Issue of Equity
06 Nov 2015 10:56 am
RNS
Holding(s) in Company
  10:56 am
RNS
Holding(s) in Company
30 Oct 2015 7:00 am
RNS
Issue of Equity
26 Oct 2015 7:00 am
RNS
Final Results
19 Oct 2015 7:00 am
RNS
Affimers improve disease resistance in plants
09 Oct 2015 7:00 am
RNS
Robust performance of Affimers on Luminex platform
08 Oct 2015 7:00 am
RNS
Notice of Results
17 Sep 2015 7:00 am
RNS
Appoints Dr Mike Owen as Non-executive Director
10 Sep 2015 7:00 am
RNS
Total Voting Rights
03 Sep 2015 7:00 am
RNS
Issue of Equity
05 Aug 2015 10:00 am
RNS
Holding(s) in Company
  10:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
04 Aug 2015 10:18 am
RNS
Issue of Equity
31 Jul 2015 10:42 am
RNS
Result of General Meeting
23 Jul 2015 7:00 am
RNS
Issue of Equity
15 Jul 2015 7:00 am
RNS
Conditional Placing to Raise up to �22.0 Million
07 Jul 2015 8:00 am
RNS
Board Change
  7:00 am
RNS
Pre-Close Trading Update
20 May 2015 11:48 am
RNS
Holding(s) in Company
19 May 2015 12:42 pm
RNS
Holding(s) in Company
18 May 2015 7:00 am
RNS
Re Agreement
11 May 2015 7:00 am
RNS
Issue of Equity
05 May 2015 7:01 am
RNS
Issue of Equity
28 Apr 2015 7:00 am
RNS
Half Yearly Report
08 Apr 2015 7:00 am
RNS
Notice of Results
23 Mar 2015 7:00 am
RNS
Drug discovery partnership
  7:00 am
RNS
Issue of Equity
12 Feb 2015 7:00 am
RNS
Sale of Optim Trade and Assets
09 Feb 2015 7:00 am
RNS
Affimer Development Contract with Protatonce
23 Jan 2015 2:31 pm
RNS
Result of AGM
  7:00 am
RNS
Trading Statement
16 Jan 2015 7:00 am
RNS
Commercial Partnership in the Agri-bio Market
06 Jan 2015 7:00 am
RNS
Issue of Equity
22 Dec 2014 7:00 am
RNS
Posting of Annual Report & Accounts and AGM Notice
16 Oct 2014 7:00 am
RNS
Final Results
30 Sep 2014 7:00 am
RNS
Affimer On-line Catalogue Launch
29 Sep 2014 7:00 am
RNS
Investor Briefing
22 Sep 2014 7:00 am
RNS
Appointment of a Senior Executive
04 Aug 2014 7:00 am
RNS
New OPTIM Software and Hardware
01 Aug 2014 7:00 am
RNS
Pre Close Trading Update
15 Jul 2014 7:00 am
RNS
Major Japanese Distributor Signed
13 Jun 2014 11:04 am
RNS
Holding(s) in Company
02 Jun 2014 1:04 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Avacta Secures Funding Award
30 May 2014 4:37 pm
RNS
Holding(s) in Company
  2:52 pm
RNS
Holding(s) in Company
29 May 2014 4:21 pm
RNS
Holding(s) in Company
28 May 2014 7:00 am
RNS
Avacta Life Sciences Exhibits Affimers at PEGS
23 May 2014 12:53 pm
RNS
Result of General Meeting
21 May 2014 5:36 pm
RNS
Holding(s) in Company
14 May 2014 7:00 am
RNS
Issue of Equity
09 May 2014 4:19 pm
RNS
Director's dealing
  7:00 am
RNS
Avacta Announce Collaboration with UbiQ Bio BV
07 May 2014 7:00 am
RNS
Conditional Placing
23 Apr 2014 7:00 am
RNS
Interim Results
14 Apr 2014 7:00 am
RNS
Avacta Launch Pancreatitis Test for Dogs
20 Mar 2014 7:00 am
RNS
Affimers : Technical and Commercial Update
11 Mar 2014 7:00 am
RNS
Notice of Interim Results
24 Feb 2014 7:00 am
RNS
Directors Dealings
05 Feb 2014 7:00 am
RNS
New Board Appointment
04 Feb 2014 9:29 am
RNS
Holding(s) in Company
03 Feb 2014 7:00 am
RNS
Avacta Initiates Collaboration with University
28 Jan 2014 7:00 am
RNS
Avacta Life Sciences Launches Affimers Web Site
24 Jan 2014 2:57 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
20 Jan 2014 7:00 am
RNS
Issue of Equity
13 Jan 2014 7:00 am
RNS
Investor teach-in
23 Dec 2013 2:59 pm
RNS
Notice of AGM and Report and Accounts
  7:00 am
RNS
Board Appointment
27 Nov 2013 10:01 am
RNS
New Canine Lymphoma Blood Test Launched
01 Nov 2013 7:00 am
RNS
Issue of Equity
24 Oct 2013 7:00 am
RNS
Preliminary Results
17 Oct 2013 7:00 am
RNS
First therapeutic licensing agreement for Affimers
26 Sep 2013 7:00 am
RNS
Launch of Sensipod - First Point of Care Test
18 Sep 2013 7:00 am
RNS
Issue of Equity and Notice of Preliminary Results
16 Sep 2013 7:00 am
RNS
New Head of R&D Joins Avacta
02 Sep 2013 5:47 pm
RNS
TR-1 Notification of Major Interest in Shares
29 Aug 2013 7:00 am
RNS
Pre-close trading update
28 Aug 2013 7:00 am
RNS
Issue of Equity
09 Aug 2013 8:35 am
RNS
TR-1: Notification of Major Interest in Shares
  8:35 am
RNS
TR-1: Notification of Major Interest in Shares
07 Aug 2013 5:51 pm
RNS
TR-1: Notification of Major Interest in Shares
  4:31 pm
RNS
TR-1: Notification of Major Interest in Shares
  4:30 pm
RNS
TR-1: Notification of Major Interest in Shares
  4:00 pm
RNS
TR-1: Notification of Major Interest in Shares
05 Aug 2013 11:00 am
RNS
Result of General Meeting
  7:00 am
RNS
Appointment of a Non-Executive Director
25 Jul 2013 7:00 am
RNS
Expansion of Collaboration with ForteBio
18 Jul 2013 7:00 am
RNS
Conditional Placing to Raise ?4.7 Million
23 May 2013 8:40 am
RNS
Holding(s) in Company
30 Apr 2013 7:00 am
RNS
Interim Results
23 Apr 2013 7:01 am
RNS
Notice of Interim Results
  7:00 am
RNS
Appointment of Nominated Advisor and Broker
27 Feb 2013 7:00 am
RNS
Interest in Affimer Technology
  7:00 am
RNS
Business Update
18 Feb 2013 5:08 pm
RNS
Additional Listing
25 Jan 2013 2:34 pm
RNS
Result of AGM
21 Jan 2013 1:20 pm
RNS
Holding(s) in Company
07 Jan 2013 3:47 pm
RNS
Holding(s) in Company
23 Oct 2012 7:00 am
RNS
Preliminary Results
24 Sep 2012 7:00 am
RNS
Avacta and Pall extend Optim distribution to India
13 Sep 2012 10:24 am
RNS
Notice of Preliminary Results
24 Aug 2012 7:00 am
RNS
Pre-close trading update
19 Jun 2012 5:05 pm
RNS
Holding(s) in Company
25 Apr 2012 7:00 am
RNS
Interim Results
02 Apr 2012 7:00 am
RNS
Avacta Signs Exclusive Supply Deal with IDEXX
15 Mar 2012 7:00 am
RNS
Notice of Interim Results
24 Jan 2012 10:39 am
RNS
Result of AGM
19 Jan 2012 6:23 pm
RNS
Holding(s) in Company
  6:23 pm
RNS
Holding(s) in Company
12 Jan 2012 11:12 am
RNS
Holding(s) in Company
10 Jan 2012 9:26 am
RNS
Completes ?5.13m placing and Aptuscan acquisition
09 Jan 2012 4:10 pm
RNS
Results of General Meeting
22 Dec 2011 7:00 am
RNS
Conditional Placing and Proposed Acquisition
08 Dec 2011 2:20 pm
RNS
Notice of AGM and Report and Accounts
25 Nov 2011 7:00 am
RNS
Additional Listing & Total Voting Rights
25 Oct 2011 7:00 am
RNS
Preliminary Results
21 Oct 2011 7:00 am
RNS
Appointment of Nomad and Broker
05 Oct 2011 7:00 am
RNS
South East Asian Alliance agreed with Pall
19 Sep 2011 7:00 am
RNS
Notice of Preliminary Results
09 Aug 2011 7:00 am
RNS
Pre-close Trading Update
06 Jul 2011 7:00 am
RNS
Change of Registered Office
13 Jun 2011 7:00 am
RNS
Avacta & Pall Corp form new collaborative venture
10 Jun 2011 12:50 pm
RNS
Director/PDMR Shareholding
31 May 2011 7:00 am
RNS
Avacta secures second Optim sale in US
18 Apr 2011 7:00 am
RNS
Interim Results
12 Apr 2011 12:42 pm
RNS
Issue of Equity
29 Mar 2011 7:00 am
RNS
Exclusive distribution agreement with DKSH Japan
28 Mar 2011 7:00 am
RNS
Additional Listing
22 Mar 2011 10:11 am
RNS
Additional Listing
17 Mar 2011 7:00 am
RNS
Directorate Change
04 Mar 2011 7:00 am
RNS
Trading Statement
23 Feb 2011 7:00 am
RNS
Re Agreement
03 Feb 2011 7:00 am
RNS
Re Agreement
  7:00 am
RNS
Issue of Equity
27 Jan 2011 4:55 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Director/PDMR Shareholding
26 Jan 2011 7:00 am
RNS
Issue of Equity
25 Jan 2011 11:57 am
RNS
Holding(s) in Company
21 Jan 2011 3:47 pm
RNS
AGM Result and Placing
12 Jan 2011 7:00 am
PRN
Placing, Issue of Equity and related party tran...
05 Jan 2011 11:59 am
PRN
Exercise of Warrants
04 Jan 2011 6:28 pm
PRN
Holding(s) in Company
  7:00 am
RNS
Product Sale
31 Dec 2010 9:57 am
PRN
Holding(s) in Company
30 Dec 2010 2:36 pm
PRN
Holding(s) in Company
25 Nov 2010 7:00 am
RNS
Product Launch
15 Nov 2010 7:00 am
PRN
Grant of Options to Directors
03 Nov 2010 7:00 am
RNS
Final Results
27 Oct 2010 7:00 am
RNS
Product Sale
26 Oct 2010 7:00 am
PRN
Issue of Equity
14 Oct 2010 7:00 am
RNS
Re Agreement
20 Sep 2010 7:00 am
PRN
Licensing Agreement
07 Sep 2010 5:08 pm
PRN
Holding(s) in Company
06 Sep 2010 7:00 am
PRN
Distribution Agreement
06 Aug 2010 9:55 am
PRN
Director/PDMR Shareholding
29 Jul 2010 7:00 am
PRN
Issue of Equity
06 Jul 2010 7:00 am
PRN
Issue of Equity
01 Jun 2010 7:00 am
PRN
Change of Adviser
30 Apr 2010 7:00 am
PRN
Half-yearly Report
08 Mar 2010 7:00 am
RNS
Notice of Results and Trading
03 Mar 2010 7:00 am
RNS
Acquisition
22 Feb 2010 2:42 pm
RNS
Director/PDMR Shareholding
25 Jan 2010 7:00 am
RNS
Result of AGM
21 Dec 2009 10:35 am
RNS
Issue of Equity
26 Nov 2009 7:03 am
RNS
Preliminary Results
  7:00 am
RNS
Issue of Equity
04 Nov 2009 7:00 am
PRN
Notice of Results
21 Oct 2009 7:00 am
PRN
Placing and Issue of Equity
06 Oct 2009 7:00 am
RNS
Optim - Second Order
28 Sep 2009 7:00 am
PRN
Re Agreement
16 Sep 2009 3:03 pm
RNS
Holding(s) in Company
11 Sep 2009 4:26 pm
RNS
Holding(s) in Company
  3:59 pm
RNS
Holding(s) in Company
07 Aug 2009 7:00 am
PRN
Pre-Close Trading Statement
28 Jul 2009 5:07 pm
RNS
Holding(s) in Company
13 Jul 2009 4:40 pm
RNS
Director/PDMR Shareholding
10 Jul 2009 4:17 pm
RNS
Issue of Equity
09 Jul 2009 4:29 pm
RNS
Further re Acquisition of The
23 Apr 2009 7:00 am
RNS
Half Yearly Report
  7:00 am
PRN
OPTIM Product Launch
31 Mar 2009 12:20 pm
PRN
Analyst Presentation
30 Mar 2009 12:59 pm
PRN
Director/PDMR Shareholding
03 Mar 2009 1:17 pm
RNS
Completion of Acquisition of
  1:17 pm
RNS
Completion of Acquisition of
02 Mar 2009 12:00 pm
RNS
Result of Court Hearing
  12:00 pm
RNS
Result of Court Hearing
12 Feb 2009 1:23 pm
RNS
Rule 8.1- (Curidium Medica Pl
  1:23 pm
RNS
Rule 8.1- (Curidium Medica Pl
11 Feb 2009 2:09 pm
RNS
Results of meetings
  2:09 pm
RNS
Results of meetings
09 Feb 2009 12:39 pm
RNS
Result of EGM
  12:39 pm
RNS
Result of EGM
  7:00 am
PRN
Acquisition
26 Jan 2009 7:00 am
PRN
Result of AGM
16 Jan 2009 7:00 am
RNS
Offer Update
  7:00 am
RNS
Offer Update
15 Jan 2009 9:24 am
PRN
Acquisition of Theragenetics Limited
09 Jan 2009 10:12 am
RNS
Avacta Group plc Acquisition
  10:12 am
RNS
Avacta Group plc Acquisition
  7:00 am
PRN
Acquisition(s)
  7:00 am
PRN
Acquisition(s)
08 Jan 2009 2:29 pm
RNS
Director/PDMR Shareholding
07 Jan 2009 7:00 am
RNS
Issue of Equity
12 Dec 2008 12:06 pm
RNS
Final Results
20 Nov 2008 4:14 pm
RNS
Director/PDMR Shareholding
05 Nov 2008 12:42 pm
RNS
Issue of Equity
04 Nov 2008 7:00 am
PRN
Final Results
13 Oct 2008 7:00 am
PRN
Change of Adviser
11 Sep 2008 7:00 am
PRN
Product Launch
21 Aug 2008 7:00 am
PRN
Trading Statement
14 Aug 2008 11:03 am
PRN
Product Development Partnership
28 Jul 2008 7:00 am
PRN
Product Launch
23 Jul 2008 2:54 pm
PRN
Director/PDMR Shareholding
22 Jul 2008 4:24 pm
PRN
Director/PDMR Shareholding
11 Jul 2008 7:00 am
PRN
Customer Agreement
14 Apr 2008 7:00 am
PRN
Half-yearly Report
04 Apr 2008 5:20 pm
RNS
Director/PDMR Shareholding
31 Mar 2008 7:00 am
RNS
Total Voting Rights
10 Mar 2008 3:12 pm
RNS
Issue of Equity
31 Jan 2008 11:36 am
RNS
Total Voting Rights
07 Jan 2008 10:50 am
PRN
Re Agreement
02 Jan 2008 5:14 pm
PRN
Issue of Equity
31 Dec 2007 7:00 am
PRN
Total Voting Rights
14 Dec 2007 3:30 pm
PRN
Acquisition(s)
  3:05 pm
PRN
AGM Statement
21 Nov 2007 7:01 am
RNS
Notice of AGM
14 Nov 2007 9:08 am
PRN
Acquisition
09 Nov 2007 4:59 pm
PRN
Directorate Appointment
25 Sep 2007 7:00 am
PRN
Final Results
03 Sep 2007 7:00 am
PRN
Re Agreement
14 Aug 2007 3:59 pm
RNS
AIM Rule 26 Information
13 Aug 2007 7:00 am
PRN
Re Agreement
31 Jul 2007 3:37 pm
RNS
Total Voting Rights
26 Jul 2007 9:53 am
PRN
Issue of Equity
05 Jul 2007 7:00 am
PRN
Re Agreement
25 Apr 2007 4:29 pm
PRN
Holding(s) in Company
10 Apr 2007 11:59 am
PRN
Director Shareholding
05 Apr 2007 12:13 pm
PRN
Total Voting Rights
04 Apr 2007 7:00 am
PRN
Placing and Appointment of joint broker
  7:00 am
PRN
Product Launch
30 Jan 2007 1:51 pm
PRN
Interim Results
21 Dec 2006 8:44 am
PRN
Total Voting Rights
29 Nov 2006 7:00 am
PRN
Re Agreement
20 Oct 2006 3:40 pm
RNS
Change of accounting ref date
11 Oct 2006 11:12 am
RNS
Annual Report and Accounts
19 Sep 2006 7:00 am
PRN
Re Agreement
24 Aug 2006 7:00 am
PRN
Collaboration Agreement
09 Aug 2006 8:03 am
PRN
Supplementary consideration shares
08 Aug 2006 8:00 am
PRN
First Day of Dealings
07 Aug 2006 12:58 pm
RNS
Result of EGM
21 Jul 2006 10:15 am
RNS
Sch 1 - Readybuy PLC
14 Jul 2006 2:20 pm
RNS
Final Results
  12:00 pm
RNS
Restoration - Readybuy PLC
  12:00 pm
RNS
Propsd Aqstn & notice of EGM
13 Jul 2006 9:30 am
RNS
Stmnt re Proposed Transaction
  8:05 am
RNS
Suspension - Readybuy PLC
07 Jul 2006 4:07 pm
RNS
Directorate Change
05 May 2006 11:24 am
RNS
Result of EGM
19 Apr 2006 3:13 pm
RNS
Further re Issue of Equity
  8:08 am
RNS
Holding(s) in Company
13 Apr 2006 5:28 pm
RNS
Holding(s) in Company
12 Apr 2006 7:44 am
RNS
Issue of Equity
09 Mar 2006 2:19 pm
RNS
Holding(s) in Company
26 Jan 2006 8:23 am
RNS
Interim Results
24 Aug 2005 7:00 am
RNS
Final Results
25 Jul 2005 7:57 am
RNS
Board change & trading update
17 Jun 2005 11:09 am
RNS
Business Strategy
25 May 2005 4:55 pm
RNS
Issue of Equity
11 Apr 2005 11:00 am
RNS
EGM Statement
23 Mar 2005 9:22 am
RNS
Issue of Equity
15 Mar 2005 3:32 pm
RNS
Notice of EGM
28 Jan 2005 4:48 pm
RNS
Interim Results
25 Oct 2004 11:27 am
RNS
Holding(s) in Company
30 Sep 2004 2:11 pm
RNS
Director Shareholding
29 Sep 2004 9:08 am
RNS
Annual Report and Accounts
23 Jun 2004 3:52 pm
RNS
Holding(s) in Company
29 Jan 2004 5:39 pm
RNS
Interim Results
09 Sep 2003 4:25 pm
RNS
Holding(s) in Company
08 Sep 2003 7:00 am
RNS
First day dealings

Top announcements

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close